Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Dissociable effects of dopaminergic medications on depression symptom dimensions in Parkinson disease ; volume:2 ; number:8 ; day:17 ; month:6 ; year:2024 ; pages:916-923 ; date:8.2024
Nature Mental Health ; 2, Heft 8 (17.6.2024), 916-923, 8.2024
- Creator
-
Costello, Harry
Schrag, Anette-Eleonore
Howard, Robert
Roiser, Jonathan P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s44220-024-00256-8
- URN
-
urn:nbn:de:101:1-2410272115363.053537546141
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Costello, Harry
- Schrag, Anette-Eleonore
- Howard, Robert
- Roiser, Jonathan P.
- SpringerLink (Online service)
Other Objects (12)
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Depression und Parkinson-Krankheit
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Depression und Parkinson-Krankheit
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment
Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
Speech Characteristics of Patients with Parkinson's Disease—Does Dopaminergic Medications Have a Role?
Erratum: Speech Characteristics of Patients with Parkinson's Disease–Does Dopaminergic Medications Have a Role?
Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
Identifying potential repurposable medications for Parkinson’s disease through Mendelian randomization analysis
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Depression und Parkinson-Krankheit
Motivational modulation of bradykinesia in Parkinson’s disease off and on dopaminergic medication
Clinical characteristics of fatigued Parkinson’s patients and the response to dopaminergic treatment